User profiles for Jackie Kleynhans
 | Jackie KleynhansEpidemiologist, National Institute for Communicable Diseases Verified email at nicd.ac.za Cited by 732 |
[HTML][HTML] SARS-CoV-2 seroprevalence in a rural and urban household cohort during first and second waves of infections, South Africa, July 2020–March 2021
J Kleynhans, S Tempia, N Wolter… - Emerging infectious …, 2021 - ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections may be underestimated
because of limited access to testing. We measured SARS-CoV-2 seroprevalence in …
because of limited access to testing. We measured SARS-CoV-2 seroprevalence in …
[HTML][HTML] Asymptomatic transmission and high community burden of seasonal influenza in an urban and a rural community in South Africa, 2017–18 (PHIRST): a …
C Cohen, J Kleynhans, J Moyes… - The Lancet Global …, 2021 - thelancet.com
Background Data on influenza community burden and transmission are important to plan
interventions especially in resource-limited settings. However, data are limited, particularly …
interventions especially in resource-limited settings. However, data are limited, particularly …
[HTML][HTML] Serotype distribution of remaining pneumococcal meningitis in the mature PCV10/13 period: findings from the PSERENADE project
Pneumococcal conjugate vaccine (PCV) introduction has reduced pneumococcal meningitis
incidence. The Pneumococcal Serotype Replacement and Distribution Estimation (…
incidence. The Pneumococcal Serotype Replacement and Distribution Estimation (…
[HTML][HTML] Global landscape review of serotype-specific invasive pneumococcal disease surveillance among countries using PCV10/13: the pneumococcal serotype …
Serotype-specific surveillance for invasive pneumococcal disease (IPD) is essential for
assessing the impact of 10- and 13-valent pneumococcal conjugate vaccines (PCV10/13). The …
assessing the impact of 10- and 13-valent pneumococcal conjugate vaccines (PCV10/13). The …
[HTML][HTML] SARS-CoV-2 incidence, transmission, and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020–21
C Cohen, J Kleynhans, A von Gottberg… - The Lancet Infectious …, 2022 - thelancet.com
Background By August, 2021, South Africa had been affected by three waves of SARS-CoV-2;
the second associated with the beta variant and the third with the delta variant. Data on …
the second associated with the beta variant and the third with the delta variant. Data on …
SARS-CoV-2 transmission, persistence of immunity, and estimates of Omicron's impact in South African population cohorts
K Sun, S Tempia, J Kleynhans, A von Gottberg… - Science Translational …, 2022 - science.org
Understanding the build-up of immunity with successive severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) variants and the epidemiological conditions that favor rapidly …
coronavirus 2 (SARS-CoV-2) variants and the epidemiological conditions that favor rapidly …
[HTML][HTML] Rapidly shifting immunologic landscape and severity of SARS-CoV-2 in the Omicron era in South Africa
K Sun, S Tempia, J Kleynhans, A Von Gottberg… - Nature …, 2023 - nature.com
South Africa was among the first countries to detect the SARS-CoV-2 Omicron variant.
However, the size of its Omicron BA.1 and BA.2 subvariants (BA.1/2) wave remains poorly …
However, the size of its Omicron BA.1 and BA.2 subvariants (BA.1/2) wave remains poorly …
Prolonged shedding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at high viral loads among hospitalized immunocompromised persons living …
…, JN Bhiman, A Buys, J Kleynhans… - Clinical Infectious …, 2022 - academic.oup.com
Background We assessed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
RNA shedding duration and magnitude among persons living with human immunodeficiency …
RNA shedding duration and magnitude among persons living with human immunodeficiency …
[HTML][HTML] Changes in Invasive Pneumococcal Disease Caused by Streptococcus pneumoniae Serotype 1 following Introduction of PCV10 and PCV13: Findings from …
Streptococcus pneumoniae serotype 1 (ST1) was an important cause of invasive pneumococcal
disease (IPD) globally before the introduction of pneumococcal conjugate vaccines (…
disease (IPD) globally before the introduction of pneumococcal conjugate vaccines (…
[HTML][HTML] Estimated impact of the pneumococcal conjugate vaccine on pneumonia mortality in South Africa, 1999 through 2016: An ecological modelling study
J Kleynhans, S Tempia, K Shioda, A Von Gottberg… - PLoS …, 2021 - journals.plos.org
Background Data on the national-level impact of pneumococcal conjugate vaccine (PCV)
introduction on mortality are lacking from Africa. PCV was introduced in South Africa in 2009. …
introduction on mortality are lacking from Africa. PCV was introduced in South Africa in 2009. …